Nexgel (NXGLW) Long-Term Deferred Tax (2021 - 2022)
Nexgel (NXGLW) reported Long-Term Deferred Tax of $4.1 million for Q4 2022, up 23.66% on a YoY basis from $3.3 million in Q4 2021, and up 23.66% quarter-over-quarter from $3.3 million in Q4 2021.
Nexgel (NXGLW) Long-Term Deferred Tax (2021 - 2022) Analysis & Trends
Nexgel has reported Long-Term Deferred Tax for 2 years, with the latest figure at $4.1 million in Q4 2022.
- For the quarter ending Q4 2022, Long-Term Deferred Tax rose 23.66% year-over-year to $4.1 million; the trailing twelve-month figure through Dec 2022 stood at $4.1 million (up 23.66% YoY), and the FY2022 full-year result was $4.1 million, up 23.66% from the prior year.
- Long-Term Deferred Tax for Q4 2022 stood at $4.1 million, up from $3.3 million in the prior quarter.
- The five-year high for Long-Term Deferred Tax was $4.1 million in Q4 2022, with the low at $3.3 million in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Nexgel | - | - | 819,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 4.12 Mn |
| Dec 31, 2021 | 3.33 Mn |